Chinmay Trivedi to Protein Kinase Inhibitors
This is a "connection" page, showing publications Chinmay Trivedi has written about Protein Kinase Inhibitors.
Connection Strength
0.644
-
Janardhan HP, Meng X, Dresser K, Hutchinson L, Trivedi CM. KRAS or BRAF mutations cause hepatic vascular cavernomas treatable with MAP2K-MAPK1 inhibition. J Exp Med. 2020 07 06; 217(7).
Score: 0.644